Detalles de la búsqueda
1.
Synthesis and biological evaluation of 3-amino-1,2,4-triazole derivatives as potential anticancer compounds.
Bioorg Chem
; 104: 104271, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32992279
2.
Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma.
Cell Rep Med
; 3(9): 100659, 2022 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36130479
3.
The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy.
Theranostics
; 11(19): 9571-9586, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34646387
4.
Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma.
Commun Biol
; 4(1): 166, 2021 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33547392
5.
Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma.
Oncoimmunology
; 9(1): 1846901, 2020 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33299657
6.
New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments.
Theranostics
; 9(18): 5332-5346, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31410218
Resultados
1 -
6
de 6
1
Próxima >
>>